Format

Send to

Choose Destination
Anesth Analg. 2016 Dec;123(6):1372-1379.

A Novel Device for the Evaluation of Hemostatic Function in Critical Care Settings.

Author information

1
From *HemoSonics LLC, Charlottesville, Virginia; and †University of Virginia, Charlottesville, Virginia.

Abstract

Major surgical procedures often result in significant intra- and postoperative bleeding. The ability to identify the cause of the bleeding has the potential to reduce the transfusion of blood products and improve patient care. We present a novel device, the Quantra Hemostasis Analyzer, which has been designed for automated, rapid, near-patient monitoring of hemostasis. The Quantra is based on Sonic Estimation of Elasticity via Resonance Sonorheometry, a proprietary technology that uses ultrasound to measure clot time and clot stiffness from changes in viscoelastic properties of whole blood during coagulation. We present results of internal validation and analytical performance testing of the technology and demonstrate the ability to characterize the key functional components of hemostasis.

PMID:
27224934
PMCID:
PMC5536171
DOI:
10.1213/ANE.0000000000001413
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center